1. Home
  2. PCVX vs IEP Comparison

PCVX vs IEP Comparison

Compare PCVX & IEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • IEP
  • Stock Information
  • Founded
  • PCVX 2013
  • IEP 1987
  • Country
  • PCVX United States
  • IEP United States
  • Employees
  • PCVX N/A
  • IEP N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • IEP Auto Parts:O.E.M.
  • Sector
  • PCVX Health Care
  • IEP Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • IEP Nasdaq
  • Market Cap
  • PCVX 4.0B
  • IEP 4.7B
  • IPO Year
  • PCVX 2020
  • IEP 1987
  • Fundamental
  • Price
  • PCVX $43.49
  • IEP $8.10
  • Analyst Decision
  • PCVX Strong Buy
  • IEP
  • Analyst Count
  • PCVX 8
  • IEP 0
  • Target Price
  • PCVX $114.17
  • IEP N/A
  • AVG Volume (30 Days)
  • PCVX 2.2M
  • IEP 640.6K
  • Earning Date
  • PCVX 11-04-2025
  • IEP 11-07-2025
  • Dividend Yield
  • PCVX N/A
  • IEP 24.72%
  • EPS Growth
  • PCVX N/A
  • IEP N/A
  • EPS
  • PCVX N/A
  • IEP N/A
  • Revenue
  • PCVX N/A
  • IEP $9,533,000,000.00
  • Revenue This Year
  • PCVX N/A
  • IEP N/A
  • Revenue Next Year
  • PCVX N/A
  • IEP $0.69
  • P/E Ratio
  • PCVX N/A
  • IEP N/A
  • Revenue Growth
  • PCVX N/A
  • IEP N/A
  • 52 Week Low
  • PCVX $27.66
  • IEP $7.27
  • 52 Week High
  • PCVX $118.62
  • IEP $15.65
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 68.94
  • IEP 37.88
  • Support Level
  • PCVX $42.75
  • IEP $8.10
  • Resistance Level
  • PCVX $45.12
  • IEP $8.24
  • Average True Range (ATR)
  • PCVX 2.10
  • IEP 0.14
  • MACD
  • PCVX 0.41
  • IEP -0.00
  • Stochastic Oscillator
  • PCVX 84.68
  • IEP 4.88

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About IEP Icahn Enterprises L.P.

Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.

Share on Social Networks: